- Home
- KNSA vs RNST Comparison
KNSA vs RNST Comparison
Compare KNSA & RNST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | KNSA | RNST |
|---|---|---|
| Founded | 2015 | 1904 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.5B | 3.7B |
| IPO Year | 2018 | 1994 |
Fundamental Metrics
Financial Performance| Metric | KNSA | RNST |
|---|---|---|
| Price | $54.87 | $40.01 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 3 |
| Target Price | ★ $60.86 | $43.00 |
| AVG Volume (30 Days) | ★ 795.8K | 573.2K |
| Earning Date | 04-28-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 2.31% |
| EPS Growth | ★ 225.00 | N/A |
| EPS | 0.27 | ★ 2.07 |
| Revenue | ★ $677,564,000.00 | N/A |
| Revenue This Year | $37.48 | $31.72 |
| Revenue Next Year | $17.87 | $4.67 |
| P/E Ratio | $198.13 | ★ $19.32 |
| Revenue Growth | ★ 60.09 | N/A |
| 52 Week Low | $25.71 | $32.63 |
| 52 Week High | $54.31 | $42.11 |
Technical Indicators
Market Signals| Indicator | KNSA | RNST |
|---|---|---|
| Relative Strength Index (RSI) | 71.26 | 60.30 |
| Support Level | $40.67 | $36.72 |
| Resistance Level | N/A | $39.99 |
| Average True Range (ATR) | 2.27 | 0.92 |
| MACD | 1.15 | -0.04 |
| Stochastic Oscillator | 96.82 | 48.94 |
Price Performance
Historical ComparisonAbout KNSA Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating cardiovascular diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and Vixarelimab. Geographically, the company earns maximum revenue from United States.
About RNST Renasant Corporation
Renasant Corp operates as a holding company for Renasant Bank, a Mississippi banking corporation, and its subsidiary, Renasant Insurance, Inc. It has two reportable segments: Community banks and Wealth management. With its Community Banks segment, the company provides a range of financial services to individuals and small businesses. The Wealth management segment provides a range of services, including money management and retirement planning. The majority of the company's revenue is driven by lending activities in its community banks segment.